Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

198 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk Factors and Outcomes of Recurrent Drug-Eluting Stent Thrombosis: Insights From the REAL-ST Registry.
Enomoto S, Kuramitsu S, Shinozaki T, Ohya M, Otake H, Yamanaka F, Shiomi H, Natsuaki M, Nakazawa G, Ando K, Kadota K, Saito S, Tamura T, Kimura T; REAL‐ST investigators †. Enomoto S, et al. Among authors: nakazawa g. J Am Heart Assoc. 2021 May 4;10(9):e018972. doi: 10.1161/JAHA.120.018972. Epub 2021 Apr 17. J Am Heart Assoc. 2021. PMID: 33870710 Free PMC article.
Clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents versus bare-metal stents in hemodialysis patients.
Yachi S, Tanabe K, Tanimoto S, Aoki J, Nakazawa G, Yamamoto H, Otsuki S, Yagishita A, Kishi S, Nakano M, Taniwaki M, Sasaki S, Nakajima H, Mise N, Sugimoto T, Hara K. Yachi S, et al. Among authors: nakazawa g. Am J Kidney Dis. 2009 Aug;54(2):299-306. doi: 10.1053/j.ajkd.2009.01.263. Epub 2009 Apr 25. Am J Kidney Dis. 2009. PMID: 19394736
Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting stent Trial (RESET).
Kimura T, Morimoto T, Natsuaki M, Shiomi H, Igarashi K, Kadota K, Tanabe K, Morino Y, Akasaka T, Takatsu Y, Nishikawa H, Yamamoto Y, Nakagawa Y, Hayashi Y, Iwabuchi M, Umeda H, Kawai K, Okada H, Kimura K, Simonton CA, Kozuma K; RESET Investigators. Kimura T, et al. Circulation. 2012 Sep 4;126(10):1225-36. doi: 10.1161/CIRCULATIONAHA.112.104059. Epub 2012 Jul 23. Circulation. 2012. PMID: 22824435 Clinical Trial.
Angiographic findings of everolimus-eluting as compared to sirolimus-eluting stents: angiographic sub-study from the Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial (RESET).
Kozuma K, Kimura T, Kadota K, Suwa S, Kimura K, Iwabuchi M, Kawai K, Miyazawa A, Kawamura M, Nakao K, Asano R, Yamamoto T, Suzuki N, Aoki J, Kyono H, Nakazawa G, Tanabe K, Morino Y, Igarashi K. Kozuma K, et al. Among authors: nakazawa g. Cardiovasc Interv Ther. 2013 Oct;28(4):344-51. doi: 10.1007/s12928-013-0179-7. Epub 2013 Apr 23. Cardiovasc Interv Ther. 2013. PMID: 23608784 Clinical Trial.
Diagnostic accuracy of Global Registry of Acute Coronary Events (GRACE) risk score in ST-elevation myocardial infarction for in-hospital and 360-day mortality in Japanese patients.
Fujii T, Suzuki T, Torii S, Murakami T, Nakano M, Nakazawa G, Masuda N, Shinozaki N, Matsukage T, Ogata N, Yoshimachi F, Ikari Y. Fujii T, et al. Among authors: nakazawa g. Circ J. 2014;78(12):2950-4. doi: 10.1253/circj.cj-14-0808. Epub 2014 Oct 6. Circ J. 2014. PMID: 25283791 Free article.
Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): Study protocol for a randomized controlled trial.
Kubo T, Shinke T, Okamura T, Hibi K, Nakazawa G, Morino Y, Shite J, Fusazaki T, Otake H, Kozuma K, Akasaka T. Kubo T, et al. Among authors: nakazawa g. J Cardiol. 2016 Nov;68(5):455-460. doi: 10.1016/j.jjcc.2015.11.007. Epub 2016 Jan 4. J Cardiol. 2016. PMID: 26763605 Free article. Clinical Trial.
198 results